Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
D1 Capital Partners L.P. CART Maplebear Inc. 13G 13.5% 2y
Nantahala Capital Management, LLC EOLS Evolus, Inc. 13G 5.1% 2y
HHLR ADVISORS, LTD. MOGU MOGU Inc. 13G/A 11.8% 2y
Jessica Warren HNST Honest Company, Inc. 13G 6.5% 2y
PRICE T ROWE ASSOCIATES INC /MD/ HCP HashiCorp, Inc. Class A Common Stock 13G/A 0.7% 2y
T. Rowe Price Investment Management, Inc. CHUY Chuy's Holdings, Inc. Common Stock 13G/A 11.1% 2y
RTW INVESTMENTS, LP XGN Exagen Inc. 13G/A 8.8% 2y
Fairmount Funds Management LLC TERN Terns Pharmaceuticals, Inc. 13G/A 9.9% 2y
Greenvale Capital LLP CARS Cars.com Inc. 13G/A 7% 2y
TANG CAPITAL MANAGEMENT, LLC TECX Tectonic Therapeutic, Inc. 13G/A 0% 2y
ARMISTICE CAPITAL, LLC AZR Azora Therapeutics, Inc. (DE) 13G 9.99% 2y
Nantahala Capital Management, LLC RMR Rmr Group Inc. 13G/A 2.6% 2y
D. E. Shaw & Co., L.P. FATP Fat Projects Acquisition Corp Class A Ordinary Share 13G/A 0% 2y
Brookfield Oaktree Holdings, LLC DUET DUET Acquisition Corp. Class A Common Stock 13G/A 0% 2y
BIOTECHNOLOGY VALUE FUND L P DCTH Delcath Systems, Inc. 13G/A 9.99% 2y
Sandia Investment Management LP ANGX Angel Studios, Inc. 13G 5.39% 2y
Lynx1 Capital Management LP CABA Cabaletta Bio, Inc. 13G/A 4.99% 2y
Marco Fregenal FTHM Fathom Holdings Inc. 13G/A 7.3% 2y
Conifer Management, L.L.C. RMNI Rimini Street, Inc. 13G/A 6.62% 2y
Radcliffe Capital Management, L.P. FRXB Forest Road Acquisition Corp. II 13G/A 0% 2y
Fort Baker Capital Management LP LVRA Levere Holdings Corp. Class A Ordinary Shares 13G/A 0% 2y
Two Seas Capital LP ESPR Esperion Therapeutics, Inc. 13G/A 6.8% 2y
Select Equity Group, L.P. BRO Brown & Brown, Inc. 13G/A 5% 2y
AMERIPRISE FINANCIAL INC AP Ampco Pittsburgh Corp 13G/A 4.93% 2y
AWM Investment Company, Inc. DXLG Destination XL Group, Inc. 13G/A 15.6% 2y
T. Rowe Price Investment Management, Inc. CTLT CATALENT, INC. 13G/A 6.2% 2y
Nathaniel Ru SG Sweetgreen, Inc. 13G/A 5.83% 2y
AWM Investment Company, Inc. BEEM Beam Global 13G 6.4% 2y
BlackRock Inc. BATRA Atlanta Braves Holdings, Inc. 13G 7.1% 2y
T. Rowe Price Investment Management, Inc. FTI TechnipFMC plc 13G 8.3% 2y
EVENTIDE ASSET MANAGEMENT, LLC MIRM Mirum Pharmaceuticals, Inc. 13G/A 5.78% 2y
PRICE T ROWE ASSOCIATES INC /MD/ KRTX Karuna Therapeutics, Inc. Common Stock 13G/A 5.2% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC ANGX Angel Studios, Inc. 13G 8.38% 2y
ARMISTICE CAPITAL, LLC REKR Rekor Systems, Inc. 13G 9.79% 2y
Lytton, Laurence W. GYRE Gyre Therapeutics, Inc. 13G/A 0% 2y
Steven J. Schwartz CBNK Capital Bancorp Inc 13G/A 5.25% 2y
AMERIPRISE FINANCIAL INC AEIS Advanced Energy Industries Inc 13G/A 6.68% 2y
PRICE T ROWE ASSOCIATES INC /MD/ RBC RBC Bearings INC 13G/A 7.1% 2y
ALLIANCEBERNSTEIN L.P. TMCI Treace Medical Concepts, Inc. 13G/A 0.1% 2y
METEORA CAPITAL, LLC WINV WinVest Acquisition Corp. 13G 7.21% 2y
Jared Isaacman FOUR Shift4 Payments, Inc. 13G/A 30.12% 2y
AQR CAPITAL MANAGEMENT LLC STI Solidion Technology Inc. 13G/A 0% 2y
CANADA PENSION PLAN INVESTMENT BOARD FUSN Fusion Pharmaceuticals Inc. Common Shares 13G/A 4.3% 2y
Radcliffe Capital Management, L.P. MACA Moringa Acquisition Corp Class A Ordinary Shares 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ CPAY Corpay, Inc. 13G 5.8% 2y
T. Rowe Price Investment Management, Inc. OBK Origin Bancorp, Inc. 13G/A 12.9% 2y
RIVERNORTH CAPITAL MANAGEMENT, LLC HUDA Hudson Acquisition I Corp. Common Stock 13G 8.89% 2y
Divisadero Street Capital Management, LP LFMD LifeMD, Inc. 13G/A 9.8% 2y
Alyeska Investment Group, L.P. APLT Applied Therapeutics, Inc. Common Stock 13G/A 9.99% 2y
Morris Goldfarb GIII G III Apparel Group Ltd 13G/A 10.2% 2y